A Study of Ustekinumab in Participants With Active Polymyositis and Dermatomyositis Who Have Not Adequately Responded to One or More Standard-of-care Treatments
Clinical trial NCT03981744 · TERMINATED
Trial details
- NCT number
- NCT03981744
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-26
- Primary completion
- 2022-01-24
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.